These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4816402)

  • 1. Eradication of hepatitis B antigen in fulminant hepatitis.
    Gitnick GL; Hantman DI; Madden SC
    West J Med; 1974 Mar; 120(3):241-4. PubMed ID: 4816402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Australia antigen (HBAg) and hepatitis].
    Grob PJ; Joller-Jemelka HI; Gassner M
    Gastroenterol Fortbildungskurse Prax; 1975; 5():106-118. PubMed ID: 1225726
    [No Abstract]   [Full Text] [Related]  

  • 3. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
    Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
    Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
    Gugenheim J; Crafa F; Fabiani P; Goubaux B; Ouzan D; Mouiel J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy and chemotherapy of viral hepatitis].
    Ito K; Onishi S; Okazaki W; Saibara T; Tachibana M; Nakata F; Yosimoto M; Nakata H; Nakazawa Y; Fukuda Y
    Nihon Rinsho; 1981 Oct; 39(10):3310-22. PubMed ID: 6175777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic aspects of acute and chronic hepatitis -- perspectives of immunotherapy (author's transl)].
    Skotnicki AB; Wolny-Niedzielska A
    Przegl Lek; 1979; 36(4):393-8. PubMed ID: 461837
    [No Abstract]   [Full Text] [Related]  

  • 8. Technical aspects and results of the determination of hepatitis associated antigen (HAA) and antibody.
    Brummelhuis HG
    Vox Sang; 1970; 19(3):228-33. PubMed ID: 4993776
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution of new markers to the diagnosis of hepatitis in dialysis].
    Matesanz R; Quereda C; Marcén R; Orofino L; Fernández Muñoz R; Bueno Vallejos R; González Sainz J; Ortuño J
    Rev Clin Esp; 1980 Nov; 159(3):171-5. PubMed ID: 7465895
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary transplant treatment of hepatitis B: hepatitis B immunoglobulin (passive immunization).
    Pruett T
    Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S13-5. PubMed ID: 9377765
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of the Australian antigen and the corresponding antibody in blood donors].
    Soulier JP
    Bibl Haematol; 1971; 37():226-30. PubMed ID: 5003065
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electron microscopical demonstration of "virus-like" particles in blood plasma units together with hepatitis associated antigen (HAA)].
    Apodaca J; Lange W; Köhler H
    Zentralbl Bakteriol Orig A; 1971 Aug; 217(4):554-62. PubMed ID: 4400255
    [No Abstract]   [Full Text] [Related]  

  • 13. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
    Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
    [No Abstract]   [Full Text] [Related]  

  • 14. Viral markers of hepatitis.
    Velasco M
    Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum markers of B virus in chronic active hepatitis].
    Segovia E; Rattoni N; Landa L
    Rev Gastroenterol Mex; 1981; 46(1):23-6. PubMed ID: 7280459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Liver disease in healthy blood donors associated with presence of hepatitis B antibody.
    Boyes BE; Woolf IL; Whittaker JS; Tapp E; Jones DM; Renton PH; Stratton F; McSween R; Dymock IW
    Gut; 1974 Apr; 15(4):341. PubMed ID: 4834573
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
    Realdi G; Alberti A; Rugge M; Bortolotti F; Rigoli AM; Tremolada F; Ruol A
    Gastroenterology; 1980 Aug; 79(2):195-9. PubMed ID: 7399226
    [No Abstract]   [Full Text] [Related]  

  • 19. [Presence and specificity of Australia antigen and the corresponding antibody].
    Arnaud R; Maupas P; Audurier A; Avril J
    Haematologia (Budap); 1970; 4(3):327-32. PubMed ID: 5001992
    [No Abstract]   [Full Text] [Related]  

  • 20. [Distribution of serologic markers of hepatitis B in a sample of the population of Cremona province].
    Romanini G; Bodini U; Pennacchio A; Cavalli P; Carpanelli R; Pecoroni L; Sampaoli G; Bini MG; D'Avossa A; Frosi A
    Riv Emoter Immunoematol; 1984; 31(2):165-73. PubMed ID: 6536097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.